A 7-gene expression signature predicts immune microenvironment remodeling and neoadjuvant chemo-immunotherapy response in lung squamous cell carcinoma.

Front Immunol · 2026 · PMC12979163 · PMID 41836378

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

HOXC13 was associated with OS and showed a trend toward association with PFS in immunotherapy-treated LUSC, supporting HOXC13 as a candidate marker related to immunotherapy outcomes.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.